Suchergebnisse - "Henry, Brandon M"

PubPharm (57)

51

Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals

enthalten in: Diagnosis (Berlin, Germany) | 2021

von Salvagno, G. | Nocini, R. | Gianfilippi, G. | +6

52

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers

enthalten in: The Journal of infection | 2021

von Salvagno, G. | Henry, B. | Pighi, L. | +3

CommentOn: J Infect. 2021 Jun 20;:null. - PMID 34161817

53

Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit

enthalten in: Advances in laboratory medicine | 2021

von Salvagno, G. | Gianfilippi, G. | Pighi, L. | +3

54

Clinical Predictors of SARS-CoV-2 Testing Pressure on Clinical Laboratories : A Multinational Study Analyzing Google Trends and Over 100 Million Diagnostic Tests

enthalten in: Laboratory medicine | 2021

von Lippi, G. | Mattiuzzi, C. | Santos de Oliveira, M. | +1

55

Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay

enthalten in: EJIFCC | 2021

von Salvagno, G. | Gianfilippi, G. | Fiorio, G. | +4

56

Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination

enthalten in: Diagnostics (Basel, Switzerland) | 2021

von Salvagno, G. | Henry, B. | di Piazza, G. | +5

57

Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreak

enthalten in: EJIFCC | 2021

von Ferrari, A. | Sanchis-Gomar, F. | Mattiuzzi, C. | +2

[1]
« Vorheriger
1
2
3
4
5
6